Paloma Partners’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAB
SCM
TCM
BC
Paloma Partners's BCAB Position: Q3 2024 in Review
Paloma Partners sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 1,944 shares — an estimated $133K sold.
Paloma Partners first reported a position in BCAB in Q2 2024 and held it in 1 quarter. The position peaked at $133K in Q2 2024. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.
- Paloma Partners reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
- Paloma Partners sold 1,944 BioAtla shares in Q3 2024, an estimated $133K.
- Paloma Partners first reported a position in BioAtla in Q2 2024 and held it in 1 quarter.
- Paloma Partners's BioAtla position peaked at $133K in Q2 2024.
- 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.
Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.